Mr Moore first joined Novo Nordisk as head of Sales and Marketing in Novo Nordisk Inc, US in 2017. Mr Moore was promoted senior vice president, Commercial at Novo Nordisk Inc, US, in 2017 and left the company in 2019.
In 2022, Mr Moore re-joined Novo Nordisk as senior vice president
of Corporate Development with responsibility for driving corporate
strategy activities as well as all business development and M&A in
Novo Nordisk.
Mr Moore was promoted executive vice president of Corporate Development in March 2023.
(Not registered as an executive of Novo Nordisk A/S with the Danish Business Authority)
Mr Moore holds broad experience in strategy, commercial, market access, business development and investing from working in both large cap pharmaceutical companies, biotech companies and within private equity.
Prior to first joining Novo Nordisk, Mr Moore was president and
chief commercial officer of Cempra Pharmaceuticals. Before joining
Novo Nordisk in 2022, Mr Moore was an investment partner at Gurnet
Point Capital, a life science focused private equity firm. Mr Moore
began his career at Johnson & Johnson, where he spent 14 years in
roles of increasing responsibility.
Mr Moore serves as a member of the board of directors of Novasenta Inc.
- 2011: Health Policy Graduate Program, Thomas Jefferson University, United States.
- 2003: MBA, Marketing, from Lehigh University, United States.
- 1997: BS, Biology, from Towson University, United States.
Mr Moore is a US national, born January 7, 1974.
